RxDoctor Payments Data

Henry Hartsoe, DO

Family Medicine · Mountain City, TNNPI 1609455880

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 11 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 6 manufacturers reported payments, led by Novo Nordisk at 28.7% of the total. That places this record below the midpoint for family medicine clinicians in TN, where the typical reported total is $470.

$210in general payments, 2019–2025

Across 11 payments — averaging $19.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$60
  • AbbVie$59
  • AstraZeneca$42
  • Lilly USA, LLC$19
  • Amgen$15
  • Exact Sciences$15
$130,974in research payments, 2019–2025

Across 3 payments — averaging $43,658 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • C. R. Bard, Inc. & Subsidiaries$131K

What the payments were for

  • Food & beverage$210100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novo Nordisk3$60
AbbVie3$59
AstraZeneca2$42
Lilly USA, LLC1$19
Amgen1$15
Exact Sciences1$15

How this compares

$210 in reported general payments places this provider in the 35th percentile of 2,087 family medicine providers in Tennessee.

See all family medicine providers in Tennessee

Medicare billing

Part B allowed, 2024
$6,387
Medicare patients
66
Services billed
84

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide11$10,572
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen36$954
Azelastine Hcl26$631
Mirtazapine19$545
Atorvastatin Calcium42$534
Duloxetine Hcl24$523
Levothyroxine Sodium43$490
Albuterol Sulfate HfaAlbuterol Sulfate16$451
Gabapentin27$447
Pantoprazole Sodium28$424
Ondansetron OdtOndansetron18$408
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen12$395
Potassium Chloride13$335
Fluticasone Propionate12$316
Omeprazole18$281

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$60$10,57211 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 35th percentile of 2,087 family medicine providers in Tennessee.

Other family medicine in Mountain City

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →